COVID-19 New Cases 698... Approaching 700 Mark

On the 14th, a clear day, a banner promoting the prohibition of gatherings of five or more people to prevent the spread of COVID-19 is displayed at Yeouido Hangang Park in Seoul. Photo by Mun Ho-nam munonam@

[Asia Economy Reporter Lee Chun-hee] The cumulative number of COVID-19 cases in South Korea was recorded at 698, slightly lower than the previous day.

The Korea Disease Control and Prevention Agency Central Disease Control Headquarters (CDCH) announced on the 15th at midnight that the total number of confirmed COVID-19 cases increased by 698 from the previous day to 112,117.

The sources of infection for the new confirmed cases were 670 local transmissions and 28 imported cases.

About 70% of the locally transmitted cases occurred in the Seoul metropolitan area. There were 216 cases (32.2%) in Seoul, 222 cases (33.1%) in Gyeonggi, and 16 cases (2.4%) in Incheon, totaling 454 cases in the metropolitan area, accounting for 67.8% of all confirmed cases.

Other regions reported new confirmed cases as follows: 54 in Busan, 22 in Gyeongnam, 21 in Ulsan, 19 in Chungbuk, 19 in Gyeongbuk, 18 in Gangwon, 16 in Daegu, 16 in Incheon, 15 in Jeonbuk, 11 in Jeonnam, 10 in Daejeon, 4 in Chungnam, 3 in Gwangju, 3 in Sejong, and 1 in Jeju.

There were 28 imported cases. Among them, 15 were detected during quarantine, and 13 were confirmed locally. Eight were Korean nationals, and 20 were foreigners.

The number of patients who have recovered and been released from isolation reached 102,513, an increase of 530 from the previous day. Among hospitalized patients, the number of critically ill patients decreased by one to 99. The death toll rose by six to 1,788.

The total number of tests conducted the previous day was 85,930. At temporary screening clinics set up in the metropolitan area, 40,192 tests were conducted, confirming 134 new cases.

Elderly people aged 75 and over are receiving vaccinations at the COVID-19 vaccination center set up in Haenuri Town, Yangcheon-gu, Seoul on the 15th. Photo by Jin-Hyung Kang aymsdream@

Meanwhile, as of midnight on the same day, 45,520 people received their first dose of the COVID-19 vaccine, bringing the total number of first-dose recipients to 1,285,909. Among them, 951,712 received the AstraZeneca vaccine, and 334,197 received the Pfizer vaccine.

The number of people who completed the second dose of the Pfizer vaccine increased by two to 60,569. The second dose of Pfizer vaccination for COVID-19 treatment hospital staff was completed as of the 10th, and for those aged 75 and older, the second dose period has not yet arrived, so only a small number of vaccinations are being conducted for some no-shows and preliminary recipients.

The number of suspected adverse reaction reports increased by 128 to a total of 11,927. There was one death each among Pfizer and AstraZeneca vaccine recipients.

Additionally, one case of anaphylaxis and one case of severe suspected symptoms such as seizures requiring intensive care unit admission were reported. The remaining 124 cases were common adverse reactions after vaccination such as muscle pain, headache, fever, chills, and nausea.

This content was produced with the assistance of AI translation services.